Europe Digital PCR (dPCR) 麻豆原创 2021-2031 by Offering , Technology , Application , End User , and Country: Trend Forecast and Growth Opportunity

Publication ID:

GRM0322023

Publication Date:

March 31, 2022

Pages:

104

Publisher:

Grace 麻豆原创 Data

Countries:

Europe [1]

USD 2,980.00

Research & Development (Pharma & Healthcare) [2]

IT & eHealth [3]

Pharma & Healthcare [4]

Description:

Europe digital PCR (dPCR) market was valued at $116.4 million in 2021 and will grow by 11.5% annually over 2021-2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities.
Highlighted with 32 tables and 50 figures, this 104-page report 鈥淓urope Digital PCR (dPCR) 麻豆原创 2021-2031 by Offering (Instruments & Accessories, Reagents & Consumables, Software & Services), Technology (Droplet, Chip-based, Beaming, Others), Application (Research, Clinical Diagnostics, Forensic, Food and Agriculture, Others), End User (Hospitals and Clinics, Pharma & Biotech Companies, Diagnostic Centers, Others), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Europe digital PCR (dPCR) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe digital PCR (dPCR) market in every aspect of the classification from perspectives of Offering, Technology, Application, End User, and Country.

Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Instruments & Accessories
鈥� Reagents & Consumables
鈥� Software & Services

Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Droplet Digital PCR
鈥� Chip-based Digital PCR
鈥� Beaming Digital PCR
鈥� Other Technologies

By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Research
鈥� Clinical Diagnostics
o Infectious diseases
o Oncology
o Genetic Disorders
o Other Indications
鈥� Forensic Testing
鈥� Food and Agriculture
鈥� Other Applications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Hospitals and Clinics
鈥� Pharma & Biotech Companies
鈥� Diagnostic Centers
鈥� Other End Users

Geographically, the following national/local markets are fully investigated:
鈥� Germany
鈥� UK
鈥� France
鈥� Spain
鈥� Italy
鈥� Russia
鈥� Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Technology, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
4basebio AG
Bio-Rad Laboratories, Inc.
Combinati, Inc.
Fluidigm Corporation
Formulatrix Inc.
JN Medsys
Merck KGaA
Qiagen N.V
RainDance Technologies
Stilla Technologies Inc.
Sysmex Corporation
Thermo Fisher Scientific, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of 麻豆原创 Research Methodology 11
1.2.2 麻豆原创 Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 麻豆原创 Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 麻豆原创 Overview and Dynamics 19
2.1 麻豆原创 Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the 麻豆原创 22
2.2 Major Growth Drivers 24
2.3 麻豆原创 Restraints and Challenges 30
2.4 Emerging Opportunities and 麻豆原创 Trends 33
2.5 Porter鈥檚 Fiver Forces Analysis 37
3 Segmentation of Europe 麻豆原创 by Offering 41
3.1 麻豆原创 Overview by Offering 41
3.2 Instruments & Accessories 43
3.3 Reagents & Consumables 44
3.4 Software & Services 45
4 Segmentation of Europe 麻豆原创 by Technology 46
4.1 麻豆原创 Overview by Technology 46
4.2 Droplet Digital PCR 48
4.3 Chip-based Digital PCR 49
4.4 Beaming Digital PCR 50
4.5 Other Technologies 51
5 Segmentation of Europe 麻豆原创 by Application 52
5.1 麻豆原创 Overview by Application 52
5.2 Research 54
5.3 Clinical Diagnostics 55
5.3.1 Infectious diseases 57
5.3.2 Oncology 58
5.3.3 Genetic Disorders 59
5.3.4 Other Indications 60
5.4 Forensic Testing 61
5.5 Food and Agriculture 62
5.6 Other Applications 63
6 Segmentation of Europe 麻豆原创 by End User 64
6.1 麻豆原创 Overview by End User 64
6.2 Hospitals and Clinics 66
6.3 Pharma & Biotech Companies 67
6.4 Diagnostic Centers 68
6.5 Other End Users 69
7 European 麻豆原创 2021-2031 by Country 70
7.1 Overview of European 麻豆原创 70
7.2 Germany 73
7.3 U.K. 75
7.4 France 77
7.5 Spain 79
7.6 Italy 81
7.7 Russia 83
7.8 Rest of European 麻豆原创 85
8 Competitive Landscape 87
8.1 Overview of Key Vendors 87
8.2 New Product Launch, Partnership, Investment, and M&A 90
8.3 Company Profiles 91
4basebio AG 91
Bio-Rad Laboratories, Inc. 93
Combinati, Inc. 94
Fluidigm Corporation 95
Formulatrix Inc. 96
JN Medsys 97
Merck KGaA 98
Qiagen N.V 99
RainDance Technologies 100
Stilla Technologies Inc. 101
Sysmex Corporation 102
Thermo Fisher Scientific, Inc. 103
RELATED REPORTS 104

Companies Mentioned:

Selected Key Players:
4basebio AG
Bio-Rad Laboratories, Inc.
Combinati, Inc.
Fluidigm Corporation
Formulatrix Inc.
JN Medsys
Merck KGaA
Qiagen N.V
RainDance Technologies
Stilla Technologies Inc.
Sysmex Corporation
Thermo Fisher Scientific, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.